[Effectiveness of transoral endoscopic thyroid surgery for lymph node dissection in the central region of thyroid cancer]. [PDF]
Wang D +5 more
europepmc +1 more source
Pharmacological and clinical evaluation of lenvatinib [PDF]
乐伐替尼是一种口服多靶点酪氨酸激酶抑制剂,2015年2月13日获得美国食品药品监督管理局(FDA)批准,用于治疗局部复发或转移病灶进展性放射性碘(131I)难治性分化型甲状腺癌(RR-DTC)。本文对乐伐替尼的药理作用、药动学、临床评价、安全性以及药物相互作用等进行了综述。Lenvatinib is an oral,multitargeted tyrosine kinase inhibitor. It was approved for the treatment of locally recurrent
许佳音, 郑建洪
core
Prognostic factors in patients with persistent/recurrent differentiated thyroid carcinoma after comprehensive treatment [PDF]
Wang J +6 more
europepmc +1 more source
Impact of microRNA-21-5p on the growth of thyroid cancer cells via targeting the recombinant sclerostin domain containing protein 1. [PDF]
Liu M, Deng H, Zhao Y, Li C, Liu H.
europepmc +1 more source
モノクローナル抗体およびレクチンによる甲状腺癌の放射免疫検出法に関する研究 [PDF]
金沢大医学部1.研究目的金沢大学癌研究所病態生理部と、研究者らの所属する金沢大学核医学教室で共同開発した申状腺癌に特異的に反応するモノクローナル抗体、および細胞膜上糖質の一定構造(Thomsen-Friedenreich抗原)と特異的に結合することを特微とするピーナツレクチンを用い、RIと標識後、動物およびヒト甲状腺癌組織培養細胞、ならびにヒト甲状腺癌移植ヌードマウスを用いた癌組織への集積の比較検討を試みた。以上の検討結果から、甲状腺癌の検出にモノクローナル抗体とレクチンのいづれが有効かを明らかにして ...
Aburano Tamio, 油野 民雄
core +1 more source
Clinicopathological features and genetic alternations in pediatric papillary thyroid carcinoma [PDF]
University of Yamanashi (山梨大学)博士(医学 ...
23559, 大石, 直輝
core
Pediatric follicular thyroid carcinoma-Indolent cancer with low prevalence of RAS mutations and absence of PAX8-PPARG fusion [PDF]
University of Yamanashi (山梨大学)博士(医科学 ...
VUONG, GIA HUY
core
Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer [PDF]
名古屋大学Nagoya University博士(医学)doctoral ...
48972 +3 more
core
[Tertiary hyperparathyroidism accompanied with thyroid carcinoma and cervical lymph node sarcoidosis: a case report]. [PDF]
Gong X +5 more
europepmc +1 more source
FTO<b>-</b>regulated m<sup>6</sup>A modification of pri<b>-</b>miR<b>-</b>139 represses papillary thyroid carcinoma metastasis. [PDF]
Li J +5 more
europepmc +1 more source

